Abstract Library

#4626 Comparison of two prognostic models for the treatment of pancreatic NET with PRRT

Introduction: The efficacy and time to progression (TTP) following peptide receptor radionuclide therapy (PRRT) for pancreatic neuroendocrine tumours varies widely.

Conference:

Presenting Author: Papantoniou D

Authors: Tiensuu Janson E, Fröss-Baron K, Grönberg M, Ziolkowska B,

Keywords: prrt, pancreatic neuroendocrine tumour, predictive model,

#4596 Gender and metastatic burden as preoperative predictors of disease progression in patients undergoing surgery for pancreatic neuroendocrine tumours with liver metastases

Introduction: Pancreatic neuroendocrine tumour liver metastases (PanNET LM) are traditionally classified into three types based on their distribution. Surgery is generally considered for patients with type I/II LM, while those with type III LM are typically regarded as unresectable. However, type III PanNET LM encompass a wide range of clinical scenarios, some of which may allow surgical resection in selected cases.

Conference:

Presenting Author: Andreasi V

Authors: Andreasi V, Partelli S, Battistella A, Muffatti F, Tamburrino D,

Keywords: Pan NET, neuroendocrine, liver metastasis, surgery, gender, progression,

#4557 miR-1290 and miR-320c regulate cell proliferation and predict patient prognosis in neuroendocrine carcinomas

Introduction: The biology of neuroendocrine carcinomas (NECs) remains largely unknown, limiting the use of biomarkers for patient stratification and therapy response prediction in clinical practice.

Conference:

Presenting Author: Liverani C

Authors: Liverani C, Sgolacchia F, Bongiovanni A, Calabrese C, Vanni S,

Keywords: biomarker, miRNAs, neuroendocrine carcinoma,

#4320 Added value of multifrequency magnetic resonance elastography in predicting pathological grading of pancreatic neuroendocrine neoplasms

Introduction: The mechanical properties of tumour tissues offer a new side for disease diagnosis.

Conference:

Presenting Author: Liu J

Authors: Liu J, Yuan J, Wen T, Wang L, Peng Z,

Keywords: magnetic resonance elastography, pancreatic neoplasm, carcinoma, neuroendocrine, pathological grade,

#4313 Identification of gastroenteropancreatic neuroendocrine tumour patients with high liver tumour burden based on clinicopathological features

Introduction: Metastatic liver tumour burden (LTB) is a prognostic factor affecting the survival of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), but evaluation of the LTB usually depends on radiologic and functional imaging.

Conference:

Presenting Author:

Authors: Jumai N, Chen L, Liu M, He Q, Zeng Z,

Keywords: liver tumour burden, prognosis, GEP-NET,